title: Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid.
authors.forename: T
authors.initials: T
authors.lastname: Kurihara
authors.forename: A
authors.initials: A
authors.lastname: Niimi
authors.forename: A
authors.initials: A
authors.lastname: Maeda
authors.forename: M
authors.initials: M
authors.lastname: Shigemoto
authors.forename: K
authors.initials: K
authors.lastname: Yamashita
mesh_terms: D000368:Aged; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001629:Bezafibrate / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage*
chemical_list: D014580:Ursodeoxycholic Acid; D001629:Bezafibrate